Journal Of Cardiovascular Pharmacology

Journal Of Cardiovascular Pharmacology

心血管药理学杂志

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Cardiovascular Pharmacology》是由Lippincott Williams and Wilkins Ltd.出版社于1979年创办的英文国际期刊(ISSN: 0160-2446,E-ISSN: 1533-4023),该期刊长期致力于心脏和心血管系统领域的创新研究,主要研究方向为心血管系统-医学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0977...%),以发表心脏和心血管系统领域等方向的原创性研究为核心(研究类文章占比75.27%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在93篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Cardiovascular Pharmacology审稿周期约为 约1月 。该刊近年未被列入国际预警名单,年发文量约93篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 93 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 84 / 220

62%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 173 / 354

51.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 88 / 220

60.23%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 168 / 354

52.68%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.1 SJR:0.61 SNIP:0.504
学科类别 分区 排名 百分位
大类:Medicine 小类:Cardiology and Cardiovascular Medicine Q2 114 / 387

70%

大类:Medicine 小类:Pharmacology Q2 150 / 313

52%

期刊发文

  • Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials

    Author: Yang, Shuai; Shen, Wen; Zhang, Hong-zhou; Wang, Chen-xi; Yu, Wan-qian; Wu, Qing-hua

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 55-62. DOI: 10.1097/FJC.0000000000001364

  • Mechanisms of SGLT2 Inhibitors in Heart Failure and Their Clinical Value

    Author: Xie, Yafei; Wei, Yujie; Li, Dan; Pu, Jie; Ding, Hong; Zhang, Xiaowei

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 4-14. DOI: 10.1097/FJC.0000000000001380

  • Effects of Recombinant Human Brain Natriuretic Peptide on Atrial Fibrillation After Coronary Artery Bypass Grafting

    Author: Wei, Yangyan; Zhang, Qian; Chi, Honghui; Wang, Ziyao; Chang, Qing

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 63-69. DOI: 10.1097/FJC.0000000000001370

  • Salidroside Regulates Mitochondrial Homeostasis After Polarization of RAW264.7 Macrophages

    Author: Wang, Xiu-Long; Sun, Rui-Xiang; Li, Dong-Xu; Chen, Zhi-Gang; Li, Xue-Fang; Sun, Si-Yu; Lin, Fei; Zhao, Guo-An

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 85-92. DOI: 10.1097/FJC.0000000000001362

  • Silencing of Long Noncoding RNA TUG1 Ameliorates Atherosclerosis-Induced Myocardial Injury by Upregulating microRNA-30b-3p and Downregulating Brd4

    Author: Li, De-long; Zheng, Bin-bin; Zeng, Xin; Li, Jiahua; Dai, Ruo-zhu

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 45-54. DOI: 10.1097/FJC.0000000000001367

  • Feedback Interaction Between Apelin and Endoplasmic Reticulum Stress in the Rat Myocardium

    Author: Jin, Sheng; Wang, Yipu; Ma, Liuchang; Zhang, Jiaqi; Huang, Panna; Zhang, Haozhe; Liu, Xinxia; Wu, Yuming; Wang, Xiaoning; Teng, Xu

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 21-34. DOI: 10.1097/FJC.0000000000001369

  • Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials

    Author: Zheng, Shaohua; Zhang, Yujiao; Gu, Lei; Ma, Kai; Wang, Xuehan; Hou, Yinglong; Zhang, Fenglei; Gao, Mei

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 2, pp. 93-103. DOI: 10.1097/FJC.0000000000001379

  • Effect of Dexmedetomidine on Cardiac Surgery Patients

    Author: Xiao, Man; Jiang, Chong-Fa; Gao, Qin; Pan, Jue; Zhang, Hong; Wu, Sheng-Nan; Dou, Mao-Sen

    Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 2, pp. 104-113. DOI: 10.1097/FJC.0000000000001384